JP2012512171A - 改善された口腔健康のための組成物及び方法 - Google Patents
改善された口腔健康のための組成物及び方法 Download PDFInfo
- Publication number
- JP2012512171A JP2012512171A JP2011540944A JP2011540944A JP2012512171A JP 2012512171 A JP2012512171 A JP 2012512171A JP 2011540944 A JP2011540944 A JP 2011540944A JP 2011540944 A JP2011540944 A JP 2011540944A JP 2012512171 A JP2012512171 A JP 2012512171A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- lactobacillus
- health
- bacteria
- streptococcus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 55
- 238000000034 method Methods 0.000 title claims abstract description 48
- 230000036541 health Effects 0.000 title claims abstract description 43
- 206010035669 Pneumonia aspiration Diseases 0.000 claims abstract description 26
- 201000009807 aspiration pneumonia Diseases 0.000 claims abstract description 26
- 230000002829 reductive effect Effects 0.000 claims abstract description 26
- 210000000214 mouth Anatomy 0.000 claims abstract description 14
- 241000894006 Bacteria Species 0.000 claims description 40
- 208000019505 Deglutition disease Diseases 0.000 claims description 34
- 244000052769 pathogen Species 0.000 claims description 27
- 230000009286 beneficial effect Effects 0.000 claims description 23
- 230000001717 pathogenic effect Effects 0.000 claims description 21
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 19
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 18
- 238000011282 treatment Methods 0.000 claims description 18
- 230000009467 reduction Effects 0.000 claims description 16
- 230000003115 biocidal effect Effects 0.000 claims description 11
- 239000003242 anti bacterial agent Substances 0.000 claims description 10
- 229940088710 antibiotic agent Drugs 0.000 claims description 10
- 241001468157 Lactobacillus johnsonii Species 0.000 claims description 9
- 241000917009 Lactobacillus rhamnosus GG Species 0.000 claims description 9
- 235000014897 Streptococcus lactis Nutrition 0.000 claims description 9
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 9
- 229940059406 lactobacillus rhamnosus gg Drugs 0.000 claims description 9
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 claims description 9
- 241000888288 Streptococcus salivarius K12 Species 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 7
- 208000015181 infectious disease Diseases 0.000 claims description 7
- 210000001989 nasopharynx Anatomy 0.000 claims description 7
- 241000194024 Streptococcus salivarius Species 0.000 claims description 6
- 210000003300 oropharynx Anatomy 0.000 claims description 6
- 239000002562 thickening agent Substances 0.000 claims description 6
- 241000186660 Lactobacillus Species 0.000 claims description 5
- 241000194017 Streptococcus Species 0.000 claims description 5
- 229940039696 lactobacillus Drugs 0.000 claims description 5
- 230000000699 topical effect Effects 0.000 claims description 5
- 238000009423 ventilation Methods 0.000 claims description 5
- 241000193163 Clostridioides difficile Species 0.000 claims description 4
- 241000191967 Staphylococcus aureus Species 0.000 claims description 4
- 235000011475 lollipops Nutrition 0.000 claims description 4
- 239000007937 lozenge Substances 0.000 claims description 4
- 208000019206 urinary tract infection Diseases 0.000 claims description 4
- 208000003322 Coinfection Diseases 0.000 claims description 3
- 206010012735 Diarrhoea Diseases 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 238000001990 intravenous administration Methods 0.000 claims description 3
- 238000000554 physical therapy Methods 0.000 claims description 3
- 230000002685 pulmonary effect Effects 0.000 claims description 3
- 206010017533 Fungal infection Diseases 0.000 claims description 2
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 claims description 2
- 208000031888 Mycoses Diseases 0.000 claims description 2
- 229960003085 meticillin Drugs 0.000 claims description 2
- 230000000474 nursing effect Effects 0.000 claims description 2
- 241000194035 Lactococcus lactis Species 0.000 claims 2
- 206010035664 Pneumonia Diseases 0.000 abstract description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 18
- 201000010099 disease Diseases 0.000 abstract description 15
- 239000006041 probiotic Substances 0.000 abstract description 15
- 235000018291 probiotics Nutrition 0.000 abstract description 15
- 244000052616 bacterial pathogen Species 0.000 abstract description 7
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 5
- 230000005802 health problem Effects 0.000 abstract description 3
- 208000007565 gingivitis Diseases 0.000 abstract description 2
- 208000008745 Healthcare-Associated Pneumonia Diseases 0.000 abstract 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 13
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 13
- 229940072205 lactobacillus plantarum Drugs 0.000 description 13
- 230000008901 benefit Effects 0.000 description 12
- 239000000126 substance Substances 0.000 description 11
- 235000013305 food Nutrition 0.000 description 9
- 244000005700 microbiome Species 0.000 description 9
- 235000016709 nutrition Nutrition 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 206010003504 Aspiration Diseases 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 8
- 241000124008 Mammalia Species 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 244000057717 Streptococcus lactis Species 0.000 description 7
- 230000007423 decrease Effects 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 235000013406 prebiotics Nutrition 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 6
- 241000193987 Streptococcus sobrinus Species 0.000 description 5
- 208000009470 Ventilator-Associated Pneumonia Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 230000009885 systemic effect Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- 241000194019 Streptococcus mutans Species 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000006866 deterioration Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000007407 health benefit Effects 0.000 description 4
- 230000028993 immune response Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 244000005706 microflora Species 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 210000003296 saliva Anatomy 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 241000186779 Listeria monocytogenes Species 0.000 description 3
- 208000018737 Parkinson disease Diseases 0.000 description 3
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 238000005202 decontamination Methods 0.000 description 3
- 230000003588 decontaminative effect Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000011785 micronutrient Substances 0.000 description 3
- 235000013369 micronutrients Nutrition 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000000529 probiotic effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000009747 swallowing Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000186044 Actinomyces viscosus Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241001608472 Bifidobacterium longum Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 206010030216 Oesophagitis Diseases 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 206010039710 Scleroderma Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 229940009291 bifidobacterium longum Drugs 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 230000006957 competitive inhibition Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000006881 esophagitis Diseases 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000030214 innervation Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 235000021073 macronutrients Nutrition 0.000 description 2
- 208000018360 neuromuscular disease Diseases 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 235000017807 phytochemicals Nutrition 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229930000223 plant secondary metabolite Natural products 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 230000003362 replicative effect Effects 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- AKXKFZDCRYJKTF-UHFFFAOYSA-N 3-Hydroxypropionaldehyde Chemical compound OCCC=O AKXKFZDCRYJKTF-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010001935 American trypanosomiasis Diseases 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 241000606123 Bacteroides thetaiotaomicron Species 0.000 description 1
- 241000606215 Bacteroides vulgatus Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000186011 Bifidobacterium catenulatum Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000006274 Brain Stem Neoplasms Diseases 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 208000024699 Chagas disease Diseases 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 206010009269 Cleft palate Diseases 0.000 description 1
- 241000584123 Commersonia johnsonii Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 102000012437 Copper-Transporting ATPases Human genes 0.000 description 1
- 241000186031 Corynebacteriaceae Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 208000014311 Cushing syndrome Diseases 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 206010013554 Diverticulum Diseases 0.000 description 1
- 201000010374 Down Syndrome Diseases 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 241000588697 Enterobacter cloacae Species 0.000 description 1
- 206010064212 Eosinophilic oesophagitis Diseases 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 208000000289 Esophageal Achalasia Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000035895 Guillain-Barré syndrome Diseases 0.000 description 1
- 206010019196 Head injury Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 208000002972 Hepatolenticular Degeneration Diseases 0.000 description 1
- 201000002563 Histoplasmosis Diseases 0.000 description 1
- 241000186399 Holdemanella biformis Species 0.000 description 1
- 208000023105 Huntington disease Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000016604 Lyme disease Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000026680 Metabolic Brain disease Diseases 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 206010062190 Metabolic encephalopathy Diseases 0.000 description 1
- 241001467578 Microbacterium Species 0.000 description 1
- 241000736262 Microbiota Species 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- 206010049567 Miller Fisher syndrome Diseases 0.000 description 1
- 208000003445 Mouth Neoplasms Diseases 0.000 description 1
- 206010028116 Mucosal inflammation Diseases 0.000 description 1
- 201000010927 Mucositis Diseases 0.000 description 1
- 208000021642 Muscular disease Diseases 0.000 description 1
- 201000009623 Myopathy Diseases 0.000 description 1
- 201000002481 Myositis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 206010030136 Oesophageal achalasia Diseases 0.000 description 1
- 206010048685 Oral infection Diseases 0.000 description 1
- 208000008558 Osteophyte Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000009565 Pharyngeal Neoplasms Diseases 0.000 description 1
- 206010034811 Pharyngeal cancer Diseases 0.000 description 1
- 208000023668 Pharyngeal disease Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 208000007519 Plummer-Vinson syndrome Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 208000010366 Postpoliomyelitis syndrome Diseases 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241001138501 Salmonella enterica Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 206010040664 Sideropenic dysphagia Diseases 0.000 description 1
- 208000021386 Sjogren Syndrome Diseases 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000004509 Tooth Discoloration Diseases 0.000 description 1
- 206010044032 Tooth discolouration Diseases 0.000 description 1
- 241000169121 Toxicum Species 0.000 description 1
- 241000223109 Trypanosoma cruzi Species 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 206010070995 Vascular compression Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000018839 Wilson disease Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000607477 Yersinia pseudotuberculosis Species 0.000 description 1
- 208000025087 Yersinia pseudotuberculosis infectious disease Diseases 0.000 description 1
- 208000008508 Zenker Diverticulum Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 241001531273 [Eubacterium] eligens Species 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 201000000621 achalasia Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 206010002022 amyloidosis Diseases 0.000 description 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 206010008129 cerebral palsy Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 230000005757 colony formation Effects 0.000 description 1
- 208000018631 connective tissue disease Diseases 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 201000001981 dermatomyositis Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 208000033420 disorder of pharynx Diseases 0.000 description 1
- 201000000708 eosinophilic esophagitis Diseases 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000009760 functional impairment Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 201000010536 head and neck cancer Diseases 0.000 description 1
- 208000014829 head and neck neoplasm Diseases 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 230000000642 iatrogenic effect Effects 0.000 description 1
- 208000036260 idiopathic disease Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000000111 lower esophageal sphincter Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000001370 mediastinum Anatomy 0.000 description 1
- 238000010197 meta-analysis Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 231100000017 mucous membrane irritation Toxicity 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 206010028417 myasthenia gravis Diseases 0.000 description 1
- 208000025402 neoplasm of esophagus Diseases 0.000 description 1
- 208000018066 neoplasm of oropharynx Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001272 neurogenic effect Effects 0.000 description 1
- 230000002232 neuromuscular Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 208000012111 paraneoplastic syndrome Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- -1 phytochemicals Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 208000005987 polymyositis Diseases 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 201000009395 primary hyperaldosteronism Diseases 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 208000025644 recurrent pneumonia Diseases 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 201000000306 sarcoidosis Diseases 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 238000007632 sclerotherapy Methods 0.000 description 1
- 231100001055 skeletal defect Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000036367 tooth discoloration Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 208000027185 varicose disease Diseases 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G3/366—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12290308P | 2008-12-16 | 2008-12-16 | |
US61/122,903 | 2008-12-16 | ||
US24082909P | 2009-09-09 | 2009-09-09 | |
US61/240,829 | 2009-09-09 | ||
PCT/US2009/067809 WO2010077795A2 (fr) | 2008-12-16 | 2009-12-14 | Compositions et méthodes pour une santé buccale améliorée |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2012512171A true JP2012512171A (ja) | 2012-05-31 |
Family
ID=42236618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011540944A Pending JP2012512171A (ja) | 2008-12-16 | 2009-12-14 | 改善された口腔健康のための組成物及び方法 |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP2379091A2 (fr) |
JP (1) | JP2012512171A (fr) |
CN (1) | CN102245191A (fr) |
AU (1) | AU2009333388A1 (fr) |
BR (1) | BRPI0922924A2 (fr) |
CA (1) | CA2747231A1 (fr) |
MX (1) | MX2011006488A (fr) |
RU (1) | RU2011129693A (fr) |
SG (1) | SG171930A1 (fr) |
WO (1) | WO2010077795A2 (fr) |
ZA (1) | ZA201105261B (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020514309A (ja) * | 2017-01-18 | 2020-05-21 | シムライズ アーゲー | 口腔内疾患関連種との凝集形成用プロバイオティクス |
KR102555748B1 (ko) * | 2023-03-23 | 2023-07-17 | 주식회사 그린스토어 | 항균, 항진균, 항염 활성 및 치아 우식 억제 활성을 갖는 신규한 스트렙토코커스 살리바리우스 균주 kccm13161p 및 이를 포함하는 구강용 조성물 |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2420580A1 (fr) * | 2010-08-18 | 2012-02-22 | AB-Biotics, S.A. | Composition probiotique pour santé buccale |
KR101166798B1 (ko) * | 2011-12-19 | 2012-07-26 | 김대현 | 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물 |
CN102533790B (zh) * | 2011-12-23 | 2013-10-02 | 光明乳业股份有限公司 | 一种检测植物乳杆菌st-ⅲ的pcr检测方法及其引物和试剂盒 |
CA2783414A1 (fr) | 2012-07-22 | 2014-01-22 | Integral Medical Inc. | Composition probiotique |
US20160015627A1 (en) | 2013-03-14 | 2016-01-21 | Nestec S.A. | Lactobacillus plantarum ncc 2936 preparations and oral health |
CN104825380A (zh) * | 2015-04-21 | 2015-08-12 | 溧水区人民医院 | 一种快速恢复口腔正常菌群的护理液及其制备方法 |
CN105193859A (zh) * | 2015-09-25 | 2015-12-30 | 南昌大学 | 一种天然口腔细菌移植在口腔疾病治疗中的应用 |
CN105193857A (zh) * | 2015-09-25 | 2015-12-30 | 南昌大学 | 一种人工培养口腔细菌移植在口腔疾病治疗中的应用 |
GB201600975D0 (en) | 2016-01-19 | 2016-03-02 | Probi Ab | Novel strain of probiotic bacteria and compositions and uses thereof |
EP3196318A1 (fr) | 2016-01-19 | 2017-07-26 | Symrise AG | Probiotiques pour modifier la composition des biofilms oraux |
CN109069556B (zh) | 2016-01-19 | 2022-11-25 | 西姆莱斯有限公司 | 用作口腔内抗炎剂的益生菌 |
CN106727819A (zh) * | 2016-12-09 | 2017-05-31 | 湖南文理学院 | 朝鲜蓟口腔清新剂的制备方法 |
CN107158040B (zh) * | 2017-04-12 | 2020-12-08 | 华南农业大学 | 一种口腔微生态制剂及其制备方法 |
CN108553406B (zh) * | 2018-07-24 | 2020-12-01 | 北京斯利安药业有限公司 | 一种组合物、其应用及具有改善口腔健康作用的口服制剂 |
CN118028182A (zh) * | 2024-04-12 | 2024-05-14 | 四川厌氧生物科技有限责任公司 | 一种改善口腔健康的约翰逊氏乳杆菌及其用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1159951A1 (fr) * | 2000-06-02 | 2001-12-05 | Societe Des Produits Nestle S.A. | Utilisation de souches de bacteries d'acide lactique exogenes pour le traitement de maladies correspondant aux Actinomyces naeslundii |
ATE501640T1 (de) * | 1998-08-12 | 2011-04-15 | Nestle Sa | Inkorporation von exogenen milchsäurebakterien in die mikroflora |
EP1260227A1 (fr) * | 2001-05-23 | 2002-11-27 | Societe Des Produits Nestle S.A. | L'acide lipoteichoique des bacteries lactiques et son utilisation pour moduler des responses immunitaites induites par des bacteries a gram negatif, gram positif |
US20040101495A1 (en) * | 2002-11-27 | 2004-05-27 | Leena Nase | Method for improving dental health |
CA2729072A1 (fr) * | 2008-06-24 | 2010-01-21 | Wm. Wrigley Jr. Company | Procede de fabrication de gomme a macher probiotique |
WO2010054439A1 (fr) * | 2008-11-14 | 2010-05-20 | Unistraw Patent Holdings Limited | Compositions probiotiques, procédés et appareil pour leur administration |
-
2009
- 2009-12-14 RU RU2011129693/15A patent/RU2011129693A/ru unknown
- 2009-12-14 CN CN2009801503950A patent/CN102245191A/zh active Pending
- 2009-12-14 WO PCT/US2009/067809 patent/WO2010077795A2/fr active Application Filing
- 2009-12-14 SG SG2011040367A patent/SG171930A1/en unknown
- 2009-12-14 AU AU2009333388A patent/AU2009333388A1/en not_active Abandoned
- 2009-12-14 MX MX2011006488A patent/MX2011006488A/es not_active Application Discontinuation
- 2009-12-14 BR BRPI0922924A patent/BRPI0922924A2/pt not_active IP Right Cessation
- 2009-12-14 CA CA2747231A patent/CA2747231A1/fr not_active Abandoned
- 2009-12-14 JP JP2011540944A patent/JP2012512171A/ja active Pending
- 2009-12-14 EP EP09793395A patent/EP2379091A2/fr not_active Withdrawn
-
2011
- 2011-07-15 ZA ZA2011/05261A patent/ZA201105261B/en unknown
Non-Patent Citations (1)
Title |
---|
JPN6013064248; Bengt Klarin, et al.: 'Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of' Crit Care 12(6), 2008, 1-8 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020514309A (ja) * | 2017-01-18 | 2020-05-21 | シムライズ アーゲー | 口腔内疾患関連種との凝集形成用プロバイオティクス |
JP7183165B2 (ja) | 2017-01-18 | 2022-12-05 | シムライズ アーゲー | 口腔内疾患関連種との凝集形成用プロバイオティクス |
KR102555748B1 (ko) * | 2023-03-23 | 2023-07-17 | 주식회사 그린스토어 | 항균, 항진균, 항염 활성 및 치아 우식 억제 활성을 갖는 신규한 스트렙토코커스 살리바리우스 균주 kccm13161p 및 이를 포함하는 구강용 조성물 |
Also Published As
Publication number | Publication date |
---|---|
SG171930A1 (en) | 2011-07-28 |
RU2011129693A (ru) | 2013-01-27 |
MX2011006488A (es) | 2011-07-13 |
CN102245191A (zh) | 2011-11-16 |
AU2009333388A1 (en) | 2011-06-30 |
WO2010077795A2 (fr) | 2010-07-08 |
CA2747231A1 (fr) | 2010-07-08 |
WO2010077795A3 (fr) | 2010-12-09 |
BRPI0922924A2 (pt) | 2017-06-06 |
EP2379091A2 (fr) | 2011-10-26 |
ZA201105261B (en) | 2012-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2012512171A (ja) | 改善された口腔健康のための組成物及び方法 | |
Teughels et al. | Probiotics and oral healthcare | |
Bomba et al. | Improvement of the probiotic effect of micro-organisms by their combination with maltodextrins, fructo-oligosaccharides and polyunsaturated fatty acids | |
Singh et al. | Probiotics: A review | |
JP5832297B2 (ja) | プロバイオティクスおよびプレバイオティクス構成要素ならびに無機塩をラクトフェリンとともに含む組成物 | |
JP5777640B2 (ja) | 腸炎症の処置における使用のためのプロバイオティクス組成物 | |
JP4455333B2 (ja) | プロバイオティック細菌:Lactobacillusfermentum | |
EP1816190B1 (fr) | Nouvelle bactérie lactique utile en tant que probiotique | |
Getachew | A review on effects of probiotic supplementation in poultry performance and cholesterol levels of egg and meat | |
EP1162987B1 (fr) | Composition pharmaceutique a usage medical et veterinaire utilisee pour regenerer la flore intestinale en cas de diarrhee ou de syndrome dyspeptique | |
Peivasteh-Roudsari et al. | Probiotics and food safety: an evidence-based review | |
ES2400187T3 (es) | Bacterias lácticas y su uso en la prevención de la diarrea | |
JP2022517754A (ja) | 菌株、組成物および使用方法 | |
Grover et al. | Probiotics–the nano soldiers of oral health | |
US20120039860A1 (en) | Compositions and methods for improved oral health | |
Onyenweaku et al. | Research Article Health Benefits of Probiotics | |
Vasile et al. | Probiotics-an alternative treatment for various diseases | |
Nagaraj et al. | Probiotics and oral health | |
Deshpande et al. | Probiotic Bacteriotherapy and Its Oral Health Perspective | |
Bharti et al. | Health benefits of probiotic bacteria as nutraceuticals | |
Babaji et al. | Role of probiotics in oral health: A review of the literature | |
Figueiredo et al. | Probiotics in human health | |
Nader | Masarwa., et al.“The Use of Probiotics in Prevention and Treatment of Oral Diseases” | |
Acharya | Probiotics: current knowledge update | |
Arjun et al. | Probiotics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120927 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140107 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140610 |